Aleksandr N. Polyakov

Aleksandr N. Polyakov

Auto-generated profile, based on publicly available information

Aleksandr N. Polyakov

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2019 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Closed access
YPYu. I. Patyutko
Yu. I. Patyutko
AKAlexey Kotelnikov
Alexey Kotelnikov
APA. N. Polyakov
A. N. Polyakov
VPV. D. Podluzhnyi
V. D. Podluzhnyi
Development of surgical approach for pancreatic head and periampullary cancer at the Blokhin National Medical Research Center of Oncology over the past 30 years and global surgical tendencies of surgery for pancreatic cancer are demonstrated in the article. Over this period, gastropancreaticoduodenectomy has evolved from standard procedure without complete lymph node dissection and neurodissection and extended gastropancreaticoduodenectomy with obligatory circular skeletonization of superior mesenteric artery and para-aortic lymphadenectomy to standard gastropancreaticoduodenectomy. The last procedure implies mandatory skeletonization of the right semicircle of superior mesenteric artery, all tubular structures of hepatoduodenal ligament and possible resection of portal and superior mesenteric vein for suspected invasion. Surgical possibilities in the treatment of patients with pancreatic head and periampullary cancer are exhausted. The concept of “early diagnosis” is not applicable for patients with ductal pancreatic cancer. Further progress is exclusively associated with medicamentous combined treatment based on the molecular-biological characteristics of pancreatic and periampular cancer and, possibly, with primary prevention of pancreatic cancer.

1 January 2019 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
PDF file
YPYu. I. Patyutko
Yu. I. Patyutko
АКА. Г. Котельников
А. Г. Котельников
AKA. G. Kriger
A. G. Kriger
IPI. S. Proskuryakov
I. S. Proskuryakov
GGG. V. Galkin
G. V. Galkin
IFI. A. Fainstein
I. A. Fainstein
To evaluate the outcomes in patients undergoing surgery for metastatic renal cell carcinoma (RCC) to the pancreas. A retrospective analysis included 54 patients with pancreatic metastases (PM) of RCC who underwent surgical treatment at the Blokhin National Cancer Medical Research Center and Vishnevsky National Medical Research Center of Surgery in 1995-2018. PM were synchronous in 6 (11%) patients and metachronous in 48 (89%) patients. Solitary metastases were identified in 35 (65%), single metastases - in 14 (26%), multiple metastases - in 5 (9%) patients. Thirty (56%) patients had isolated PM, 24 (44%) patients - PM associated with another metastatic site. The following surgical procedures were performed: distal pancreatectomy (n=30, 55%), pancreatoduodenectomy (n=12, 21%), total pancreatectomy (n=6, 12%), pancreatic head resection (n=3, 6%), middle-preserving pancreatectomy (n=1, 2%), middle pancreatectomy (n=1, 2%), cryosurgical destruction of tumor (n=1, 2%). Median blood loss was 950 ml (interquartile range 400-1800 ml). Postoperative complications occurred in 52% patients. The 90-day mortality rate was 6%, overall 5-year survival 74±7%, median - 84 months. Surgery is associated with an acceptable perioperative complications and long-term survival in patients with synchronous and metachronous, solitary and multiple PM of RCC, including cases of extrapancreatic disease. This approach may be considered as a management option in these patients.

20 September 2022 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
AKAlexey Kotelnikov
Alexey Kotelnikov
YPYu. I. Patyutko
Yu. I. Patyutko
DPD. V. Podluzhny
D. V. Podluzhny
MSM. S. Saakyan
M. S. Saakyan
NKN. E. Kudashkin
N. E. Kudashkin
ЮПЮ. И. Патютко
Ю. И. Патютко
The paper presents the results of various studies and meta-analyses which focus on assessing the frequency of formation of clinically significant pancreatic fistulas in various types of pancreatic-digestive anastomoses. Pancreatodigestive anastomosis is not an independent predictive factor of pancreatic complications. None of the modern types of pancreatodigestive anastomosis has proved its superiority. The choice of the pancreatodigestive anastomosis method is based on the correct selection of the organ with which the pancreatic stump is connected and the surgeon’s experience and skill in forming the anastomosis.

23 April 2023 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
APA.N. Polyakov
A.N. Polyakov
YPYu.I. Patyutko
Yu.I. Patyutko
NKN.E. Kudashkin
N.E. Kudashkin
DKD.M. Kantieva
D.M. Kantieva
KRK.A. Romanova
K.A. Romanova
DPD.V. Podluzhnyi
D.V. Podluzhnyi
ЦЕЛЬ ИССЛЕДОВАНИЯ Определить целесообразность необратимой электропорации (НЭП) при местно-распространенной аденокарциноме поджелудочной железы на основе собственного опыта и данных литературы. МАТЕРИАЛ И МЕТОДЫ С 2015 по 2022 г. 23 пациентам выполнена НЭП по поводу местно-распространенного рака поджелудочной железы после индукционной химиотерапии. НЭП чаще проводили во время лапаротомии (n=22). В 1 случае ее сочетали с паллиативной панкретодуоденальной резекцией. После процедуры адъювантную химиотерапию получили 19 (86,3%) пациентов. Контрольное обследование включало КТ/МРТ брюшной полости с внутривенным контрастированием, рентгенографию или КТ органов грудной клетки, определение опухолевого маркера CA 19-9 через 1 мес после операции, затем каждые 3 мес. РЕЗУЛЬТАТЫ Осложнения после НЭП развились у 5 (21,7%) пациентов. У 3 (13,0%) больных отмечена аритмия, у 3 (8,7%) — панкреонекроз. Девяностодневная летальность после процедуры составила 4,3% (n=1), причина — панкреонекроз. По интраоперационным данным и результатам первого обследования (КТ/МРТ) весь опухолевый инфильтрат был обработан в 21 (91,3%) случае. Медиана времени наблюдения составила 19 мес. Медиана времени до местного рецидива составила 15 мес. Изолированный локальный рецидив наблюдался у 7 больных, 3 из них проведена лучевая терапия, 1 — повторная НЭП. Отдаленные метастазы обнаружены у 11 больных; системная терапия была возобновлена. Медиана времени до прогрессирования составила 7 мес после НЭП и 14 мес после начала индукционной химиотерапии. Медиана общей выживаемости составила 16 мес после электропорации и 25 мес после индукционной химиотерапии. ЗАКЛЮЧЕНИЕ Необратимая электропорация может быть применима у тщательно отобранных пациентов с местно-распространенной аденокарциномой поджелудочной железы после успешной индукционной химиотерапии. Метод обеспечивает локальный контроль, но влияние на отдаленные результаты и целесообразность рутинного использования следует определить в рандомизированных исследованиях.

19 March 2023 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
AKAlexey Kotelnikov
Alexey Kotelnikov
YPY. I. Patyutko
Y. I. Patyutko
DPD. V. Podluzhnyi
D. V. Podluzhnyi
MSM. S. Saakyan
M. S. Saakyan
NKN. E. Kushlinski
N. E. Kushlinski
ЮПЮ. И. Патютко
Ю. И. Патютко
At present, pancreaticoduodenoctomy causes the high incidence of complications. However, it is associated with an acceptable level of postoperative mortality. With this regard and taking into consideration a significant increase in survival in pancreatic cancer, it is highly relevant to study the negative functional outcomes of surgery and develop methods for their surgical prevention. The bibliographic review focuses on the features of three main postsurgical syndromes: gastric stasis, pancreatic exocrine and endocrine insufficiency. The study shows the dependence of these syndromes on pathomorphological characteristics of pancreatic stump, preservation of the pyloric, the variant of pancreatodigestive anastomosis and other features of reconstructive stage of the surgery.

22 December 2019 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Closed access
PDF file
YPYu. I. Patyutko
Yu. I. Patyutko
AIA. A. Ivanov
A. A. Ivanov
DPD. V. Podluzhny
D. V. Podluzhny
AKAlexey Kotelnikov
Alexey Kotelnikov
APA. N. Polyakov
A. N. Polyakov
ЮПЮ. И. Патютко
Ю. И. Патютко
Повторные резекции печени у больных колоректальным раком с метастазами